Skip to content

Biohaven BHVN Accrued Expenses

Accrued Expenses at other companies

Eli Lilly logo
Eli LillyLLY
$1.36B+22.0%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$8.72M+39.8%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$68.11M-34.6%
uniQure logo
uniQureQURE
$43.2M+58.0%
Roivant Sciences logo
Roivant SciencesROIV
$583K-50.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$17.49M+47.7%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's accrued expenses?
Biohaven (BHVN) reported accrued expenses of $4.43M in Q1 2026.
How has Biohaven's accrued expenses changed year-over-year?
Biohaven's accrued expenses decreased by 32.1% year-over-year, from $6.53M to $4.43M.
What is the long-term trend for Biohaven's accrued expenses?
Over 4 years (2021 to 2025), Biohaven's accrued expenses has grown at a -18.0% compound annual growth rate (CAGR), from $37.16M to $16.78M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.